EuroEyes International Eye Clinic Limited (HK:1846)
:1846
Want to see HK:1846 full AI Analyst Report?
1846 Stock Chart & Stats
HK$3.00
-HK$0.02(-0.53%)
At close: 4:00 PM EST
HK$3.00
-HK$0.02(-0.53%)
Day’s Range― - ―
52-Week RangeHK$2.42 - HK$3.46
Previous CloseN/A
Volume15.00K
Average Volume (3M)156.72K
Market Cap
HK$799.43M
Enterprise ValueHK$550.59M
Total Cash (Recent Filing)HK$696.70M
Total Debt (Recent Filing)HK$410.19M
Price to Earnings (P/E)14.7
Beta0.17
Next Earnings
Aug 27, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield1.99%
Share Statistics
EPS (TTM)0.17
Shares Outstanding320,706,000
10 Day Avg. Volume164,000
30 Day Avg. Volume156,720
Financial Highlights & Ratios
PEG Ratio-0.56
Price to Book (P/B)0.78
Price to Sales (P/S)1.22
P/FCF Ratio6.56
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Stable Cash GenerationConsistently positive operating cash flow and a recovery in free cash flow provide durable internal funding for clinic upkeep, selective expansion, and dividends. Strong cash conversion reduces reliance on capital markets and supports operational resilience through cycles in elective healthcare demand.
Solid Balance Sheet Equity BaseA sizable equity base relative to assets gives the company financial resilience to absorb shocks, fund working-capital swings, and support strategic capex. This structural capital buffer underpins long-term clinic operations and provides flexibility for growth or opportunistic M&A without immediate solvency pressure.
Revenue Growth ResumedA return to positive top-line growth signals recovering patient volumes or pricing power in elective ophthalmic services. Sustained revenue growth supports utilization of clinical capacity and provides the base for margin recovery and reinvestment in service quality and geographic expansion over the medium term.
Bears Say
Profitability DeclineEarnings fell materially while revenue rose, indicating margin compression from higher costs, pricing mix shifts, or operational inefficiencies. Sustained weaker profitability would erode reinvestment capacity and reduce the durability of cash returns to shareholders absent structural margin improvements.
Weakened Return On EquityA sharp drop in ROE over recent years signals reduced ability to generate returns from shareholders' capital. If persistently low, this undermines long-term capital efficiency, makes new equity issuance more dilutive, and raises questions about management effectiveness in deploying capital.
Rising Leverage In 2025An uptick in absolute debt raises interest and refinancing risk and narrows financial flexibility for expansion or cushioning profit shocks. Even with historically manageable leverage, the step-up in debt is a structural watch item that can constrain investment choices and increase sensitivity to interest-rate conditions.
EuroEyes International Eye Clinic Limited News
1846 FAQ
What was EuroEyes International Eye Clinic Limited’s price range in the past 12 months?
EuroEyes International Eye Clinic Limited lowest stock price was HK$2.42 and its highest was HK$3.46 in the past 12 months.
What is EuroEyes International Eye Clinic Limited’s market cap?
EuroEyes International Eye Clinic Limited’s market cap is HK$799.43M.
When is EuroEyes International Eye Clinic Limited’s upcoming earnings report date?
EuroEyes International Eye Clinic Limited’s upcoming earnings report date is Aug 27, 2026 which is in 76 days.
How were EuroEyes International Eye Clinic Limited’s earnings last quarter?
EuroEyes International Eye Clinic Limited released its earnings results on Mar 31, 2026. The company reported HK$0.05 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.05.
Is EuroEyes International Eye Clinic Limited overvalued?
According to Wall Street analysts EuroEyes International Eye Clinic Limited’s price is currently Overvalued.
Does EuroEyes International Eye Clinic Limited pay dividends?
EuroEyes International Eye Clinic Limited pays a Quarterly dividend of HK$0.013 which represents an annual dividend yield of 1.99%. See more information on EuroEyes International Eye Clinic Limited dividends here
What is EuroEyes International Eye Clinic Limited’s EPS estimate?
EuroEyes International Eye Clinic Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does EuroEyes International Eye Clinic Limited have?
EuroEyes International Eye Clinic Limited has 320,706,000 shares outstanding.
What happened to EuroEyes International Eye Clinic Limited’s price movement after its last earnings report?
EuroEyes International Eye Clinic Limited reported an EPS of HK$0.05 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 0.372%.
Which hedge fund is a major shareholder of EuroEyes International Eye Clinic Limited?
Currently, no hedge funds are holding shares in HK:1846
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
EuroEyes International Eye Clinic Limited Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
-32.87%
12-Months-Change
Fundamentals
Return on Equity
4.33%
Trailing 12-Months
Asset Growth
22.06%
Trailing 12-Months
Company Description
EuroEyes International Eye Clinic Limited
EuroEyes International Eye Clinic Limited provides comprehensive vision correction services across Germany, Denmark, and the People's Republic of China. Their extensive array of procedures encompasses advanced refractive laser surgeries, such as ReLEx SMILE and FemtoLASIK, alongside phakic lens (ICL) implantation. They also perform various lens exchange surgeries, including both monofocal and trifocal options, in addition to offering PRK/LASEK and ICRS implantation services. These treatments are designed to address a spectrum of eye conditions, including myopia (nearsightedness), high myopia, presbyopia (age-related farsightedness), and cataracts. EuroEyes caters to a clientele predominantly in the mid-to-high income bracket. This demographic typically includes younger individuals seeking surgical solutions for myopia, as well as those aged 45 and older primarily requiring treatment for presbyopia or cataracts. The company manages a network of consultation centers, specialized eye treatment clinics, and dedicated LASIK centers. Furthermore, it engages in the sale of pharmaceutical products. Beyond direct patient care, EuroEyes diversifies its operations through the trading of eye clinic equipment and lenses, alongside ophthalmic equipment rental and managing operational spaces. Established in 1993, EuroEyes International Eye Clinic Limited maintains its headquarters in Hamburg, Germany.
Technical Analysis
Chaoju Eye Care Holdings Ltd.
―
C-MER Eye Care Holdings Limited
―
Hospital Corporation of China Ltd
―
Town Health International Medical Group Ltd.
―
UMP Healthcare Holdings Limited
―
Options Prices
Currently, No data available
---